Skip to main content
Erschienen in: World Journal of Surgery 6/2010

01.06.2010

Removal of Autografted Parathyroid Tissue for Recurrent Renal Hyperparathyroidism in Hemodialysis Patients

verfasst von: Yoshihiro Tominaga, Susumu Matsuoka, Nobuaki Uno, Toyonori Tsuzuki, Takahisa Hiramitsu, Norihiko Goto, Takaharu Nagasaka, Yoshihiko Watarai, Kazuharu Uchida

Erschienen in: World Journal of Surgery | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Recurrent renal hyperparathyroidism (HPT) is a serious problem after parathyroidectomy (PTx). We evaluated the frequency of graft-dependent recurrent HPT and the clinical outcomes after removal of the autograft.

Methods

Between March 1980 and January 2009, 2660 patients underwent total PTx with forearm autograft. After resection of all parathyroid glands, 30 pieces of 1 × 1 × 3 mm parathyroid tissue from diffuse hyperplasia, if possible, were autografted into brachioradial muscle. Graft-dependent recurrence of HPT was diagnosed by a high PTH gradient and detection of swollen autografts by palpation and/or MRI or US.

Results

In 248/2660 (9.3%) patients, removal of the graft was required a total of 327 times (53 patients required removal of the autograft several times). The cumulative frequency of graft-dependent recurrent HPT was 17.4% ten years after the initial PTx. Thirty-two patients underwent both resection of missed glands located in the neck or mediastinum and removal of the graft. En-bloc resection of autograft with surrounding muscle was required to avoid reoperation. When the intact PTH level dropped under 300 pg/ml, in the majority of patients renal HPT could be medically managed after the operation. The mean weight of the resected parathyroid tissue was 1583.7 mg. No specimen had histopathologically malignant features. Three patients suffered from hematoma in the wound.

Conclusions

Graft-dependent recurrent renal HPT is not negligible. However, in the majority of patients, renal HPT can be controlled by removal of the autograft noninvasively. Total PTx with forearm autograft is preferable for hemodialysis patients, especially when long-term survival is expected.
Literatur
1.
Zurück zum Zitat Block GA, Klassen PS, Lazarus JM et al (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis patients. J Am Soc Nephrol 15:2208–2218CrossRefPubMed Block GA, Klassen PS, Lazarus JM et al (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis patients. J Am Soc Nephrol 15:2208–2218CrossRefPubMed
2.
Zurück zum Zitat Tominaga Y, Matsuoka S, Uno N (2009) Surgical and medical treatment of secondary hyperparathyroidism in patients on continuous dialysis. World J Surg 33(11):2335–2342CrossRefPubMed Tominaga Y, Matsuoka S, Uno N (2009) Surgical and medical treatment of secondary hyperparathyroidism in patients on continuous dialysis. World J Surg 33(11):2335–2342CrossRefPubMed
3.
Zurück zum Zitat National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1–S140 National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1–S140
4.
Zurück zum Zitat Andia JBC, Drueke TB, Cunningham J et al (2000) Clinical algorithms on renal osteodystrophy. Nephrol Dial Transplant 15(Suppl 5):2–57 Andia JBC, Drueke TB, Cunningham J et al (2000) Clinical algorithms on renal osteodystrophy. Nephrol Dial Transplant 15(Suppl 5):2–57
5.
Zurück zum Zitat Japanese Society for Dialysis Therapy (2008) Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients. Ther Apher Dial 12:514–525CrossRef Japanese Society for Dialysis Therapy (2008) Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients. Ther Apher Dial 12:514–525CrossRef
6.
Zurück zum Zitat Tominaga Y (2006) Surgical treatment of secondary hyperparathyroidism due to chronic kidney disease. Ups J Med Sci 111:277–292CrossRefPubMed Tominaga Y (2006) Surgical treatment of secondary hyperparathyroidism due to chronic kidney disease. Ups J Med Sci 111:277–292CrossRefPubMed
7.
Zurück zum Zitat Tominaga Y, Matsuoka S, Sato T (2005) Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease. Ther Apher Dial 9:44–47CrossRefPubMed Tominaga Y, Matsuoka S, Sato T (2005) Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease. Ther Apher Dial 9:44–47CrossRefPubMed
8.
Zurück zum Zitat Tominaga Y (2008) Current status of parathyroidectomy for secondary hyperparathyroidism in Japan. NDT Plus 1(Suppl 3):iii35–iii38CrossRef Tominaga Y (2008) Current status of parathyroidectomy for secondary hyperparathyroidism in Japan. NDT Plus 1(Suppl 3):iii35–iii38CrossRef
9.
Zurück zum Zitat Hibi Y, Tominaga Y, Sato T et al (2002) Reoperation for renal hyperparathyroidism. World J Surg 26:1301–1307CrossRefPubMed Hibi Y, Tominaga Y, Sato T et al (2002) Reoperation for renal hyperparathyroidism. World J Surg 26:1301–1307CrossRefPubMed
10.
Zurück zum Zitat De-Francisco AL, Amado JA, Casanova D et al (1991) Recurrence of hyperparathyroidism after total parathyroidectomy with autotransplantation: a new technique to localize source of hormone excess. Nephron 58:306–309CrossRefPubMed De-Francisco AL, Amado JA, Casanova D et al (1991) Recurrence of hyperparathyroidism after total parathyroidectomy with autotransplantation: a new technique to localize source of hormone excess. Nephron 58:306–309CrossRefPubMed
11.
Zurück zum Zitat Malberti F, Marcelli D, Conte F et al (2001) Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study. J Am Soc Nephrol 12:1242–1248PubMed Malberti F, Marcelli D, Conte F et al (2001) Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study. J Am Soc Nephrol 12:1242–1248PubMed
12.
Zurück zum Zitat Basile C, Lomonte C, Vernaglione L et al (2006) A high body mass index and female gender are associated with an increased risk of nodular hyperplasia of parathyroid glands in chronic uraemia. Nephrol Dial Transplant 21:968–974CrossRefPubMed Basile C, Lomonte C, Vernaglione L et al (2006) A high body mass index and female gender are associated with an increased risk of nodular hyperplasia of parathyroid glands in chronic uraemia. Nephrol Dial Transplant 21:968–974CrossRefPubMed
13.
Zurück zum Zitat Jorna FH, Tobe TJM, Huisman RM et al (2004) Early identification of risk factors for refractory secondary hyperparathyroidism in patients with long-term renal replacement therapy. Nephrol Dial Transplant 19:1168–1173CrossRefPubMed Jorna FH, Tobe TJM, Huisman RM et al (2004) Early identification of risk factors for refractory secondary hyperparathyroidism in patients with long-term renal replacement therapy. Nephrol Dial Transplant 19:1168–1173CrossRefPubMed
14.
Zurück zum Zitat Stratton J, Simcock M, Thompson H (2003) Predictors of recurrent hyperparathyroidism after total parathyroidectomy in chronic renal failure. Nepron Clin Pract 95:c15–c22CrossRef Stratton J, Simcock M, Thompson H (2003) Predictors of recurrent hyperparathyroidism after total parathyroidectomy in chronic renal failure. Nepron Clin Pract 95:c15–c22CrossRef
15.
Zurück zum Zitat Rothmund M, Wagner PK, Schark C (1991) Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: a randomized trial. World J Surg 15:745–750CrossRefPubMed Rothmund M, Wagner PK, Schark C (1991) Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: a randomized trial. World J Surg 15:745–750CrossRefPubMed
16.
Zurück zum Zitat Hargrove GM, Pasieka JL, Hanley DA et al (1999) Short- and long-term outcome of total parathyroidectomy with immediate autografting versus subtotal parathyroidectomy in patients with end-stage renal disease. Am J Nephrol 19:559–564CrossRefPubMed Hargrove GM, Pasieka JL, Hanley DA et al (1999) Short- and long-term outcome of total parathyroidectomy with immediate autografting versus subtotal parathyroidectomy in patients with end-stage renal disease. Am J Nephrol 19:559–564CrossRefPubMed
17.
Zurück zum Zitat Zaraca F, Mazzaferro S, Catarci M et al (1999) Prospective evaluation of total parathyroidectomy and autotransplantation for the treatment of secondary hyperparathyroidism. Arch Surg 134:68–72CrossRefPubMed Zaraca F, Mazzaferro S, Catarci M et al (1999) Prospective evaluation of total parathyroidectomy and autotransplantation for the treatment of secondary hyperparathyroidism. Arch Surg 134:68–72CrossRefPubMed
18.
Zurück zum Zitat Feldman AL, Sharaf RN, Skarulis MC et al (1999) Results of heterotopic parathyroid autotransplantation: a 13-year experience. Surgery 126:1042–1048CrossRefPubMed Feldman AL, Sharaf RN, Skarulis MC et al (1999) Results of heterotopic parathyroid autotransplantation: a 13-year experience. Surgery 126:1042–1048CrossRefPubMed
19.
Zurück zum Zitat Skinner KA, Zuckerbraun L (1996) Recurrent secondary hyperparathyroidism. Arch Surg 131:724–727PubMed Skinner KA, Zuckerbraun L (1996) Recurrent secondary hyperparathyroidism. Arch Surg 131:724–727PubMed
20.
Zurück zum Zitat Zhong A, Billa V, Rotstein LE et al (2000) Recurrence of hyperparathyroidism after total parathyroidectomy and autotransplantation in peritoneal dialysis patients. Perit Dial Int 20:200–208PubMed Zhong A, Billa V, Rotstein LE et al (2000) Recurrence of hyperparathyroidism after total parathyroidectomy and autotransplantation in peritoneal dialysis patients. Perit Dial Int 20:200–208PubMed
21.
Zurück zum Zitat Niederle B, Roka R, Brennan MF (1982) The transplantation of parathyroid tissue in man: development, indication, technique and results. Endocr Rev 3:245CrossRefPubMed Niederle B, Roka R, Brennan MF (1982) The transplantation of parathyroid tissue in man: development, indication, technique and results. Endocr Rev 3:245CrossRefPubMed
22.
Zurück zum Zitat Tominaga Y, Tanaka Y, Sato K et al (1992) Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissue. World J Surg 16:595–603CrossRefPubMed Tominaga Y, Tanaka Y, Sato K et al (1992) Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissue. World J Surg 16:595–603CrossRefPubMed
23.
Zurück zum Zitat Tominaga Y, Tanaka Y, Sato K et al (1996) DNA studies in graft dependent hyperparathyroidism. Acta Chir Austriaca 28(Suppl 124):65–68 Tominaga Y, Tanaka Y, Sato K et al (1996) DNA studies in graft dependent hyperparathyroidism. Acta Chir Austriaca 28(Suppl 124):65–68
24.
Zurück zum Zitat Neyer U, Hoerandner H, Haid A et al (2002) Total parathyroidectomy with autotransplantation in renal hyperparathyroidism: low recurrence after intra-operative tissue selection. Nephrol Dial Transplant 17:625–629CrossRefPubMed Neyer U, Hoerandner H, Haid A et al (2002) Total parathyroidectomy with autotransplantation in renal hyperparathyroidism: low recurrence after intra-operative tissue selection. Nephrol Dial Transplant 17:625–629CrossRefPubMed
25.
Zurück zum Zitat Hampl H, Steinmuller T, Frohling P et al (1999) Long-term results of total parathyroidectomy without autotransplantation in patients with and without renal failure. Miner Electrolyte Metab 25:161–170CrossRefPubMed Hampl H, Steinmuller T, Frohling P et al (1999) Long-term results of total parathyroidectomy without autotransplantation in patients with and without renal failure. Miner Electrolyte Metab 25:161–170CrossRefPubMed
26.
Zurück zum Zitat Lorenz K, Ukkat J, Sekulla C et al (2006) Total parathyroidectomy without autotransplantation for renal hyperparathyroidism: experience with a qPTH-controlled protocol. World J Surg 30:743–751CrossRefPubMed Lorenz K, Ukkat J, Sekulla C et al (2006) Total parathyroidectomy without autotransplantation for renal hyperparathyroidism: experience with a qPTH-controlled protocol. World J Surg 30:743–751CrossRefPubMed
27.
Zurück zum Zitat Ljutic D, Cameron JS, Ogg CS et al (1994) Long-term follow-up after total parathyroidectomy without parathyroid reimplantation in chronic renal failure. QJM 87:685–692PubMed Ljutic D, Cameron JS, Ogg CS et al (1994) Long-term follow-up after total parathyroidectomy without parathyroid reimplantation in chronic renal failure. QJM 87:685–692PubMed
28.
Zurück zum Zitat Stracke S, Jehle PM, Sturm D et al (1999) Clinical course after total parathyroidectomy without autotransplantation in patients with end-stage renal failure. Am J Kidney Dis 33:304–311CrossRefPubMed Stracke S, Jehle PM, Sturm D et al (1999) Clinical course after total parathyroidectomy without autotransplantation in patients with end-stage renal failure. Am J Kidney Dis 33:304–311CrossRefPubMed
29.
Zurück zum Zitat Shih ML, Duh QY, Hsieh CB et al (2009) Total parathyroidectomy without autotransplantation for secondary hyperparathyroidism. World J Surg 33:248–254CrossRefPubMed Shih ML, Duh QY, Hsieh CB et al (2009) Total parathyroidectomy without autotransplantation for secondary hyperparathyroidism. World J Surg 33:248–254CrossRefPubMed
30.
Zurück zum Zitat Aly A, Douglas M (2003) Embryonic parathyroid rests occur commonly and have implications in the management of secondary hyperparathyroidism. ANZ J Surg 73:284–288CrossRefPubMed Aly A, Douglas M (2003) Embryonic parathyroid rests occur commonly and have implications in the management of secondary hyperparathyroidism. ANZ J Surg 73:284–288CrossRefPubMed
31.
Zurück zum Zitat Uno N, Tominaga Y, Matsuoka S et al (2008) Incidence of parathyroid glands located in thymus in patients with renal hyperparathyroidism. World J Surg 32:2516–2519CrossRefPubMed Uno N, Tominaga Y, Matsuoka S et al (2008) Incidence of parathyroid glands located in thymus in patients with renal hyperparathyroidism. World J Surg 32:2516–2519CrossRefPubMed
32.
Zurück zum Zitat Richards ML, Wormuth J, Bingener J et al (2006) Parathyroidectomy in secondary hyperparathyroidism: Is there an optimal operative management? Surgery 139:174–180CrossRefPubMed Richards ML, Wormuth J, Bingener J et al (2006) Parathyroidectomy in secondary hyperparathyroidism: Is there an optimal operative management? Surgery 139:174–180CrossRefPubMed
33.
Zurück zum Zitat Klempa I, Frei U, Rottger P et al (1984) Parathyroid autograft morphology and function: six years’ experience with parathyroid autotransplantation in uremic patients. World J Surg 8:540–544CrossRefPubMed Klempa I, Frei U, Rottger P et al (1984) Parathyroid autograft morphology and function: six years’ experience with parathyroid autotransplantation in uremic patients. World J Surg 8:540–544CrossRefPubMed
34.
Zurück zum Zitat Wells SA, Gunnells JC, Shelbourne JD et al (1975) Transplantation of parathyroid glands in men: clinical indications and results. Surgery 78:34–44PubMed Wells SA, Gunnells JC, Shelbourne JD et al (1975) Transplantation of parathyroid glands in men: clinical indications and results. Surgery 78:34–44PubMed
35.
Zurück zum Zitat Tominaga Y, Tsuzuki T, Matsuoka S et al (2008) Expression of parafibromin in distant metastatic parathyroid tumors in patients with advanced secondary hyperparathyroidism due to chronic kidney disease. World J Surg 32:815–821CrossRefPubMed Tominaga Y, Tsuzuki T, Matsuoka S et al (2008) Expression of parafibromin in distant metastatic parathyroid tumors in patients with advanced secondary hyperparathyroidism due to chronic kidney disease. World J Surg 32:815–821CrossRefPubMed
36.
Zurück zum Zitat Matsuoka S, Tominaga Y, Sato T et al (2006) Recurrent renal hyperparathyroidism caused by parathyromatois. Word J Surg 31:299–305CrossRef Matsuoka S, Tominaga Y, Sato T et al (2006) Recurrent renal hyperparathyroidism caused by parathyromatois. Word J Surg 31:299–305CrossRef
37.
Zurück zum Zitat Lomonte C, Antonelli M, Losurdo N et al (2007) Cinacalcet is effective in relapses of secondary hyperparathyroidism after parathyroidectomy. Nephrol Dial Transplant 22:2056–2062CrossRefPubMed Lomonte C, Antonelli M, Losurdo N et al (2007) Cinacalcet is effective in relapses of secondary hyperparathyroidism after parathyroidectomy. Nephrol Dial Transplant 22:2056–2062CrossRefPubMed
38.
Zurück zum Zitat Silverberg SJ, Rubin MR, Faiman C et al (2007) Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. J Clin Endocrinol Metab 92:3803–3808CrossRefPubMed Silverberg SJ, Rubin MR, Faiman C et al (2007) Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. J Clin Endocrinol Metab 92:3803–3808CrossRefPubMed
39.
Zurück zum Zitat Eriguchi R, Umakoshi J, Tominaga Y et al (2008) Successful treatment of inoperable recurrent secondary hyperparathyroidism with cinacalcet HCl. NDT Plus 4:218–220CrossRef Eriguchi R, Umakoshi J, Tominaga Y et al (2008) Successful treatment of inoperable recurrent secondary hyperparathyroidism with cinacalcet HCl. NDT Plus 4:218–220CrossRef
Metadaten
Titel
Removal of Autografted Parathyroid Tissue for Recurrent Renal Hyperparathyroidism in Hemodialysis Patients
verfasst von
Yoshihiro Tominaga
Susumu Matsuoka
Nobuaki Uno
Toyonori Tsuzuki
Takahisa Hiramitsu
Norihiko Goto
Takaharu Nagasaka
Yoshihiko Watarai
Kazuharu Uchida
Publikationsdatum
01.06.2010
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 6/2010
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-010-0412-9

Weitere Artikel der Ausgabe 6/2010

World Journal of Surgery 6/2010 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.